Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gigacloud Technology Inc (GCT) vs 22nd Century Group Inc (XXII) Price & Performance

Gigacloud Technology IncTrade
22nd Century Group IncTrade

Price performance (Past 24H)

Key statistics

Gigacloud Technology Inc vs 22nd Century Group Inc — how do they compare? Gigacloud Technology Inc trades at $37.97 (market cap $1.40B), while 22nd Century Group Inc trades at $4.27 (market cap $1.52M). The key difference: Gigacloud Technology Inc is far larger — about 921.1× 22nd Century Group Inc's market cap. Which is the better fit depends on your goals.

GCTXXII
Market Cap
$1.40B$1.52M
Sector
TechnologyTechnology
52-Week High
$51.80$1.47K
52-Week Low
$20.97$3.90
Enterprise Value
$1.51B-$6.71M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Gigacloud Technology Inc

GigaCloud Technology (GCT) trades at $37.85, up 6.91% with strong earnings momentum after beating Q1 2026 EPS estimates. The stock shows bullish technical signals despite mixed indicators, with valuation ratios appearing attractive (P/E 9.49, P/S 1.02). Recent recognition as TIME's World Growth Leader and expanding international presence highlight operational strength.

GCT presents compelling value with robust profitability (32.14% ROE) and consistent earnings beats, though technical overbought conditions and competitive pressures warrant caution. The 66.7% analyst buy rating supports upside potential, but investors should monitor execution risks in international expansion.

22nd Century Group Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Gigacloud Technology Inc

Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.

Read more on GCT

About 22nd Century Group Inc

22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.

Read more on XXII